Buy These 3 Stocks Before the FDA's Anticipated Announcement

See this ASAP! This could NOT be more urgent.... Ian King has identified 3 little-known stocks that could go up 10X in the coming years. It's all thanks to a breakthrough product that could save billions of lives. Maybe even yours.

CDC Advisor Panel Recommends RSV Shots In US For People Above 75 Years, Analyst Says Decision Negative For GSK

Vandana Singh
June 27, 2024

On Wednesday, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted to recommend the routine use of Respiratory Syncytial Virus (RSV) vaccines in all adults aged 75 and above.

The panel also recommended RSV immunization for adults aged 60-74 years who are at increased risk for severe RSV disease, meaning they have certain chronic medical conditions.

The recommendation is for adults who did not get an RSV vaccine last year. The RSV vaccine is not currently an annual vaccine.

ACIP postponed a vote on a recommendation for adults aged 50-59 years at increased risk for RSV-LRTD until additional data become available.

GSK Plc (NYSE:GSK) says it continues to generate data.

The updated recommendation for people 60 and older replaces last year’s recommendation to simplify RSV vaccine decision-making for clinicians and the public.

Earlier this month, the FDA expanded the approval of GSK’s Arexvy for the prevention of RSV lower respiratory tract disease (LRTD) in adults 50 through 59 years at increased risk, becoming the first and only vaccine FDA-approved for adults aged 50-59 who are at increased risk for RSV-LRTD.

In the U.S., the vaccine was approved for use in adults aged 60 and older.  

In April, Pfizer Inc (NYSE:PFE) released top-line immunogenicity and safety data from Phase 3 MONeT trial, evaluating a single dose of Abrysvo versus placebo in adults 18 to 59 years of age at risk of developing severe RSV-LRTD.

Citing JP Morgan analyst, Reuters highlights, “We believe consensus Arexvy forecasts may now be lowered to reflect a smaller eligible U.S. patient population, confirmed Moderna Inc (NASDAQ:MRNA) competition, and more risk around GSK’s two-year revaccination interval.”

The report also added, “The decision is a negative for GSK, which makes the Arexvy RSV vaccine.”

Also Read: Why Is Moderna Stock Trading Lower On Wednesday?

Price Action: GSK shares are down 1.80% at $38.15 during the premarket session at the last check on Thursday.

Photo by JHVEPhoto on Shutterstock

Continue Reading...

Popular

These Are The Top Democratic Contenders Who Could Succeed Biden If President Were To Bow Out Of

In the wake of a debate performance that drew widespread criticism, speculation has been reignited about whether President Joe Biden should bow out before the November election.

Trump's Family Reacts To Attempted Assassination: 'Toughest Man I've Ever Met'

Following the attempted assassination of former President Donald Trump on Saturday, his family shared heartfelt messages.

This Could Be Like Buying Crypto In 2020 - Ad

Wall Street veteran Ian King says, "this could be like buying crypto in 2020." Now Ian's pounding the table on a new opportunity that's on the cusp of mainstream adoption just like crypto in 2020. And he's recommending you buy 3 little-known stocks ahead of an official announcement from the U.S. government.

Wall Street's Most Accurate Analysts Weigh In On 3 Energy Stocks With Over 6% Dividend Yields

During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors turn to dividend-yielding stocks.

Gunman Dead, Trump Rally Attendee Killed, Says Local DA: Former President Comes Under Fire In Pennsylvania

Shooter at Trump rally in PA is dead, attendee killed. Trump safe, being evaluated. Biden calls for unity. Musk endorses Trump after shooting.

Your Second Chance to Profit from AI - Ad

If you missed out on Nvidia, don't worry. A 244-year-old pattern is about to trigger a $25.6 trillion AI surge... And send three overlooked stocks soaring 1,000%+

Big Tech Is Spending Billions Each Month on This AI Superproject - Ad

Big Tech is committing billions each month to the construction of these AI mega data centers. This is where Nvidia, comes in. It's quietly leaning on a set of what we call Silent Partners to get the job done. These companies could benefit greatly from this next wave of the AI boom.

Micron Shares Slipping 8% After Hours 'Bad News' But 'Good News' Is The AI Trade Is Intact, Says Gene Munster

Micron Technology Inc. experienced a significant drop of nearly 8% in after-hours trading, following its latest earnings report. However, Gene Munster, the managing partner at Deepwater Asset Management, remains optimistic about the company's AI prospects.

Military to spend billions on "Living Missile" - Ad

We've just prepared a new report on the small defense contractor that makes this weapon - plus three other small defense firms best positioned to ride this mega-trend...

Outside Last Week's Debate, Trump Gained Momentum With Two Major Supreme Court Developments — For Better Or Worse

Former U.S. President Donald Trump has experienced a series of political triumphs this week, following President Joe Biden's lackluster performance in their inaugural debate and two positive Supreme Court rulings.

July 22nd - The Biggest Crypto Event in History - Ad

According to the man who called every major market top and bottom for the last 29 years... A single event triggering on June 24th will send the crypto market soaring. But what's more exciting... is that this event could send a small sector of the crypto market soaring 5X, 25X, and even 100X higher in just days.

Royal Caribbean Stock Is Rising Tuesday: What's Going On?

Royal Caribbean Cruises Ltd (NYSE:RCL) shares are trading higher Tuesday in sympathy with shares of Carnival Corp (NYSE:CCL), which jumped after the company reported better-than-expected quarterly results.

What's Going On With Nikola Stock After Its Reverse Split?

Nikola Corporation shares are trading lower Tuesday after the stock began trading on a reverse split-adjusted basis. Here's a look at what to know:

This Is Where the World's Richest Men Are Putting Their Money - Ad

Bill Gates, Peter Thiel, Mark Zuckerberg -- they're pouring millions into something we call Imperium technology. And you can invest in this tech alongside them starting with just $10. Bill Gates called Imperium "one of the most powerful technologies of the 21st century."

Bitcoin Continues Sideways Despite $21M ETF Inflow On Wednesday

Bitcoin spot ETFs saw net inflows of $21.5 million, signaling a shift in investor sentiment. Experts will discuss this and more at Benzinga's event.

UBS Sells Stake In China Joint Venture To Comply with Local Regulations: Report

UBS selling partial stake in securities joint venture to BSAM in China, consolidating operations, CEO says it's optimal move for compliance.

Seven Unknown AI Stocks That Could Dominate the Next Six Years - Ad

The original "Magnificent Seven" stocks generated 16,800% over the last 20 years. But now a new set of AI stocks is set to take over. Alex Green dubs them "The Next Magnificent Seven." And he's arguing that just $1,000 in each could turn into more than $1 million in less than six years.

Joe Biden's Debate Performance Triggers Democratic Panic: 'Biden Sounds Hoarse, Looks Tired And Is Babbling'

President Joe Biden faced a challenging time during the recent presidential debate, leaving Democrats anxious about his ability to secure a second term.

Michael Jackson Faced Over $500 Million Worth Of Debt At Time Of Death, Filings Show

Recent court filings reveal that the estate of pop legend Michael Jackson was in debt to the tune of over $500 million at the time of his death in 2009.

Are Banks Already Using Your ESG Score Against You? - Ad

As we speak, the powers that be are building a full-scale social credit system ...And soon, it could be used to control the way you live your life. Legendary financial forecaster, Dr. Martin Weiss recorded an urgent message on how to prepare, including the three steps you should consider RIGHT NOW.

Rivian Stock Skyrockets Premarket, Set To Open At 4-Month High: What's Going On?

EV startup Rivian has found the going tough along with the rest of its peers as demand falters amid an inclement economy.

What's Going On With Cheche Group Shares Today?

Cheche Group shares rise as it expands insurance collaborations with BAIC Group's Beijing Anpeng, enhancing ties with new energy vehicle manufacturers in China.

This AI Stock Surges Nearly 3% Premarket As SoftBank Reportedly Plans To Launch AI-Powered Medical Service In Japan

SoftBank Group is set to introduce a medical service in Japan that uses artificial intelligence to analyze personal medical data, including genetic information. The service will be launched through a joint venture with U.S. healthcare company Tempus AI Inc.

Forget AI, Imperium Is Expected to Grow 320,000% In 3 Years - Ad

Three of the world's biggest AI companies -- Google, Nvidia and Intel -- have even partnered with my No. 1 Imperium company to get on this massive mega trend. The average investor hasn't caught on yet, but you can still invest in my No. 1 Imperium company for just $10 a share.

Bitcoin Rebounds From ETF Outflows, Back Above $61K

Bitcoin (CRYPTO: BTC) has bounced from its poor showing in Monday trading and is trading back above $61,000, despite significant net outflows from spot ETFs.

Biden Administration Proposes New Rule To Protect 36M Workers From Heat-Related Injuries

The Biden administration has introduced a new rule to address excessive heat in the workplace, aiming to protect millions of workers from heat-related illnesses.

New Trump Bombshell - Ad

The Freeport Society and Louis Navellier have just issued a shocking election prediction for 2024. I believe Donald J. Trump will go down as America's last Republican president. But NOT for the reasons you may think...

Rivian Enhances Older R1 Models With New Software Update Following Gen-2 Unveiling

EV maker Rivian Automotive Inc on Friday said that it has a few upgrades in store for its first generation R1 owners in its latest software update, including suspension software enhancements and a redesigned user interface.

Target will stop accepting personal checks next week. Are the days of the payment method numbered?

NEW YORK (AP) — Target will no longer accept personal checks from shoppers as of July 15, another sign of how a once ubiquitous payment method is going the way of like floppy disks and the Rolodex.

Exposed: 3 Cent Crypto to Explode July 22nd? - Ad

Chris Rowe, the man who spotted 44 different coins that have returned over 100%, is now making the biggest crypto call of his ENTIRE career.... Because a powerful crypto event will trigger on June 24th... Sending hundreds of tiny cryptos soaring 5X, 50X, even 100X -- in just days.

The End of America's Global Leadership - Ad

Believe it or not, this October surprise could end up being the real election story when historians write their books. And no matter who wins, it may be impossible to restore America's global standing afterwards.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright smartmoneytrading.net
Privacy Policy | Terms of Service